XML 35 R54.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements - Changes in fair value of Level 3 liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Business Combination Contingent Consideration Liability [Roll Forward]      
Acquisition-related accrued interest $ (79) $ 0 $ (132)
Level 3      
Business Combination Contingent Consideration Liability [Roll Forward]      
Acquisition-related accrued interest     (125)
Balance at December 31, 2019 $ (7,678)   (7,678)
Osprey Biotechnics, Inc. ("Osprey") | Level 3      
Business Combination Contingent Consideration Liability [Roll Forward]      
Acquisition     $ (7,553)